Genetic Testing Services

Selected news for Genetic Testing Services, representing 4% of data collected since 10/2017. Recent stories appear in PR Newswire and PRWeb. This healthcare topic shares news with Reproductive Health, Steve Chapman, Mike Brophy, Genomics and dozens of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
1/4/2021 The Ridgway Record ridgwayrecord.com FT. MYERS, FL 4, 2021 / NeoGenomics, Inc. ( NASDAQ:NEO ), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Douglas VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief Financial Officer, Dr. Lawrence Weiss, Chief Medical Officer, and Doug Brown, Chief Strategy and Corporate Development Officer will be presenting at the virtual 39 th Annual J.P. Morgan Healthcare Conference 2021 on Monday ...
1/1/2021 Genetic Testing Services Market 2020-2026 Wordpress.com A New Research Report Added by Research Trades on Genetic Testing Services Market With Covid-19 Trending AnalysisGenetic Testing Services market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Genetic Testing Services market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and ...
12/18/2020 The impact of COVID-19 on Genetic Testing Services Market 2020 Global Industry Trends, Growth, Share, Size and 2026 Forecast Research Report adifymedia.com The impact of COVID-19 on Genetic Testing Services Market 2020 Global Industry Trends, Growth, Share, Size and 2026 Forecast Research Report latest report as Genetic Testing Services Market acknowledges Size, Application Segment, Type, Regional Outlook, Market Demand, Latest Trends, and Genetic Testing Services Industry Share & Revenue by Manufacturers, Leading Companies Profiles, Future Growth Potential Forecasts-2025. In the next few years, analyses the current market size and development in ...
12/11/2020 Genetic Testing Services Market Growth, Size, Share and Forecast 2019-2025 heraldkeeper.com December 11, 2020The global Genetic Testing Services market is projected to have a considerable CAGR during the forecast period. The growing prevalence of chronic diseases such as cancer, infectious diseases across the globe further contributes to the growth of the genetic testing services market. As per the International Agency for Research on Cancer (IARC), in 2018 there were 17 million new cancer cases and 9.5 million cancer mortality across ...
11/17/2020 Top Ranked Momentum Stocks to Buy for November 17th - November 17, 2020 - Zacks.com Zacks ... Äôs growth of 4.1%. The company possesses a Momentum Score of A.Semler Scientific Inc. Price Semler Scientific Inc. price Semler Scientific Inc. QuoteFulgent Genetics, Inc. ( FLGT Quick Quote FLGT - Free Report ) : This genetic testing services provider has a Zacks Rank 1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.Fulgent Genetics, Inc. Price and Consensus Fulgent ...
11/14/2020 NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020 sproutnews.com ... Newsroom Contact Us NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020FT. MYERS, FL / ACCESSWIRE / November 13, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Doug VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief Financial Officer and Doug Brown, Chief Strategy and Corporate Development Officer, will be participating ...
11/10/2020 NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests sproutnews.com ... Liquid Biopsy TestsNational In-Home Blood Sample Collection Through ExamOne® and Metro Health Staffing, LLCFT MEYERS, FL / ACCESSWIRE / November 9, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today the launch of a mobile phlebotomy service for its blood-based tests, including InVisionFirst®-Lung, its advanced non-small cell lung cancer liquid biopsy ...
11/2/2020 Invitae (NVTA) to Report Q3 Earnings: What's in the Cards? - November 2, 2020 - Zacks.com Zacks ... tests and biopharma programs, is expected to have driven third-quarter results.The company’s non-invasive prenatal screening (NIPS) using maternal cell-free DNA has been strengthening its portfolio of comprehensive women's health genetic testing services lately. This is expected to show on third-quarter results.Per management, Invitae is focused on investing in widening its genome network and signing biopharma partnerships, thereby strengthening the capabilities of the platform ...
10/1/2020 NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020 itbusinessnet.com FT. MYERS, FL NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services , announced today that it plans to release its third quarter 2020 financial results on Tuesday, October 27, 2020.The Company has scheduled a webcast and conference call to discuss their third quarter results on Tuesday, October 27, 2020 at 8:30 AM EDT. Interested investors should dial (844) 602-0380 (domestic) and (862) 298-0970 (international) at ...
9/29/2020 Fulgent Genetics (NASDAQ:FLGT) Upgraded to “Buy” by Zacks Investment Research Ticker Report ... in a research report report published on Monday morning, Zacks.com reports. Zacks Investment Research currently has $44.00 price target on the stock. According to Zacks, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals ...
9/28/2020 Reviewing Natera (NASDAQ:NTRA) and ACI Global (NASDAQ:ACGJ) equitiesfocus.com N/A About Natera Natera, Inc., a diagnostics company, provides preconception and prenatal genetic testing services . It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the ...
9/24/2020 Analysis of COVID-19 on Preclinical Animal Behavior Market | Market to See High Growth Due to the Increasing Prevalence of Chronic Conditions | Technavio Business Wire ... animal telemetry and large animal telemetry), and geography (North America, Europe, Asia, and ROW). Global Animal Genetics Market – Global animal genetics market by geography (Asia, Europe, North America, and ROW) and solution (live animal, genetic testing services , and genetic materials). About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market ...
9/24/2020 Medicare Issues Draft Local Coverage Determination for Signatera™ in Immunotherapy Response Monitoring PR Newswire ... a focus on women's health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California . It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com . Follow Natera on LinkedIn . Forward-Looking Statements ...
9/22/2020 Stock Alert: Fulgent Genetics Up 7% On Addition To S&P SmallCap 600 rttnews.com Shares of Fulgent Genetics, Inc. ( FLGT ), a provider of genetic testing services , are rising more than 7 percent or $2.79 in Tuesday's morning trade at $40.38. Monday, S&P Dow Jones Indices said that Fulgent Genetics will replace Garrett Motion Inc. (GTX) in the S&P SmallCap 600 Index, effective prior to the opening of trading on Friday, September 25. Garrett Motion is filing for bankruptcy protection and is ineligible ...
9/21/2020 Demand for Genetic Testing Services Grows Strong amid Economic Turmoil Spurred by COVID-19 Pandemic Fact.MR Report thecloudtribune.com Tania Crowe September 21, 2020 No Comments Genetic Testing Services market Growth Fact.MR has come up with a study on Genetic Testing Services Market and the report is laden with information that can be utilized by stakeholders in the market to make informed decisions. Analysts have widely utilized the well-entrenched and effective market intelligence tools to collect and collate and then present the analysis and assessment of the Genetic ...